Home-based FES Training in People With Chronic Stroke

Recruiting now · Not applicable

Conditions studied: Chronic Stroke

In brief

This project will examine the feasibility, safety and effect of home-based functional electrical stimulation (FES) applied to different lower limb muscles in combination with task-specific training on gait, balance and mobility in adults with chronic stroke. 30 individuals with chronic stroke will first undergo initial screening and baseline walking, mobility, balance and strength assessments in the laboratory. After determining their eligibility for the study, they will undergo 12-weeks of home-based FES and task-specific training. Following the initial screening (week 1) and pre-intervention assessment (week 2), participants will be trained in the lab for 6 sessions (week 3-4) for a FES home program and then given a FES home kit (FES device and an android tablet). Participants will then undergo home-training for 2 weeks (week 5-6) followed by mid-training assessment (week 7). Again, participants will undergo 4-weeks of home training (week 8-11) and final assessment at the end of training (week 12). This project has the following specific aims: Aim 1: To investigate the feasibility, safety and efficacy of 12-weeks of home-based FES and task-specific training in adults with chronic stroke. Aim 2: To examine the effect of 12-weeks of home-based FES and task-specific training on mobility, gait and balance (anticipatory and reactive balance) in adults with chronic stroke.

Key facts

Study ID

NCT05849532

Run by

University of Illinois at Chicago

People needed

30

Starts

2022-12-10

Expected to finish

2027-03-30

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age group: 18-90 years.
• Presence of unilateral hemiparesis.
• Onset of stroke (> 6 months).
• Ability to walk independently with or without an assistive device for at least 300 ft.
• Can understand and communicate in English and can verbalize discomfort or pain in English
• Use of smartphone on a daily basis
• Availability of internet/Wi-Fi at home

You may not qualify if…

• Body weight more than 250 lbs.
• Heel bone density measurement using an ultrasound device. Individuals classified as osteoporotic (i.e., with a T-score < -2) will be excluded.
• Cognitive impairment (Montreal Cognitive assessment score <26/30)
• Verbal Aphasia (i.e <71% score on Mississippi Aphasia Screening)
• Severe depression (> 15 points on geriatric depression scale)
• Any neurological condition other than stroke.
• Uncontrolled and/or untreated hypertension/hypotension, uncontrolled and/or untreated diabetes and any musculoskeletal, neuromuscular or systemic diagnosis .
• Recent major surgery (< 6 months) or hospitalization (< 3 months).
• Deep venous thrombosis.
• Past or current history of any type of active cancer
• Peripheral nerve injury or neuropathy in the affected limb with motor disability.
• Uncontrolled high blood pressure/angina.
• Skin condition not tolerant with FES therapy.
• Past or current history of uncontrolled/controlled epilepsy or any other types of seizure disorders
• Botox treatment within the last 5 months.
• Pacemaker users.

Where it is running

• University of Illinois at Chicago — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.